Author Question: An agent making a proper contract with a third person on behalf of a disclosed principal: A) has no ... (Read 102 times)

JGIBBSON

  • Hero Member
  • *****
  • Posts: 538
An agent making a proper contract with a third person on behalf of a disclosed principal:
 A) has no personal liability on the contract.
 B) is liable only to the principal on the contract.
 C) is liable only to the third party on the contract.
 D) is personally liable to both the principal and the third person on the contract.

Question 2

The incentives for self-policing, disclosure, correction and prevention provides lesser penalties and sanctions:
 A)For first-time violators.
 B)For violators who came forward voluntarily.
 C)For whistleblowers who report their own companies.
 D)None of the above



Jmfn03

  • Sr. Member
  • ****
  • Posts: 323
Answer to Question 1

A

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

Illicit drug use costs the United States approximately $181 billion every year.

Did you know?

There are immediate benefits of chiropractic adjustments that are visible via magnetic resonance imaging (MRI). It shows that spinal manipulation therapy is effective in decreasing pain and increasing the gaps between the vertebrae, reducing pressure that leads to pain.

Did you know?

Drug abusers experience the following scenario: The pleasure given by their drug (or drugs) of choice is so strong that it is difficult to eradicate even after years of staying away from the substances involved. Certain triggers may cause a drug abuser to relapse. Research shows that long-term drug abuse results in significant changes in brain function that persist long after an individual stops using drugs. It is most important to realize that the same is true of not just illegal substances but alcohol and tobacco as well.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library